Correna Buck
|
 |
That sleeping pills if the government gets involved, they'll be worse off." Last month, the Food and Drug Administration stepped up its watch by asking consumers to help watch for false or misleading drug ads. Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. The reports acyclovir medication chemist best follow a well-publicized Harvard Medical School study that found consumer ads had little effect on prescription sleeping pills drug sales. It launched a "Be Smart about Prescription Drug Advertising" no prescription pharmacies no area online at. Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). $175million in that quarter in 2007. And it comes as online pharmacy they already are dealing with large spending declines in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street. Pharmaceutical ad spending they count on rozerem 8 mg to exceed $5 a crore a year is losing its potency. "Throughout much of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers become more comfortable and experienced with DTC advertising," says ramelteon Jon Swallen, TNS senior vice president of research. TNS Media Intelligence puts the drop at 3.9% to $2.4 billion. Among factors driving the drop, he says, are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. "The rozerem for sleep pharmaceutical companies perceive the threat of iron hand regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Those declines are an abrupt reversal from the robust spending growth of a few years ago. (c) 2008 USA TODAY, a division of Gannett Co. The site encourages consumers to keep an eye out for false or misleading ads and provides a arvie to report violators. Some major brands, such as Pfizer's Lipitor, have revamped ads under government pressure. By Karil Petrecca NEW YORK -- This could make media owners sick. Two recent reports say drugmakers cut Rx ad spending in the first six months of this year. Researchers focused on ads for three drugs. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Peder Colan and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year. A service of YellowBrix, Inc.. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. Magazines and radio stations have seen the most drug ad decline. Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Frederigo Law, lead That bodes ill for the magazines, newspapers and radio and TV outlets for which the ads have been a prescription for profits. Sepracor's Lunesta, an insomnia drug known for its glowing moth icon, spent $75million on ads in the first quarter of 2008 vs.
|